重庆三峡油漆股份有限公司关于处置部分北陆药业股票的进展公告

Core Viewpoint - The company plans to dispose of part of its shares in Beijng Beilu Pharmaceutical Co., Ltd. to enhance asset liquidity and focus on core business development [1][2]. Group 1: Stock Disposal Details - The company intends to sell up to 10 million shares of Beijng Beilu Pharmaceutical within three months after the pre-disclosure announcement of the reduction plan [1]. - As of the latest update, the company has sold 3 million shares of Beijng Beilu Pharmaceutical at an average price of approximately 10.22 CNY per share, totaling a transaction amount of 30,665,658 CNY [1][2]. Group 2: Financial Impact - The sale of 3 million shares is expected to increase the company's net profit by approximately 18.55 million CNY after deducting costs and related transaction taxes [2]. - The company still holds 34,465,700 shares of Beijng Beilu Pharmaceutical, representing 6.12% of its total share capital [2].